Microfragmented Adipose Tissue Injection (MFAT) May Be a Solution to the Rationing of Total Knee Replacement: A Prospective, Gender-Bias Mitigated, Reproducible Analysis at Two Years

Table 5

Tabulated data for Figure 5.

Gender	OKS period	Count	Mean	Median	SD	Data
Female	0	9	42.6	42.0	2.5	d1
Female	1	9	39.8	41.0	6.5	d1
Female	2	9	40.4	39.0	5.9	d1
Female	3	9	40.9	41.0	4.7	d1
Female	4	9	38.8	38.5	3.9	d1
Male	0	31	42.5	42.0	2.4	d1
Male	1	31	40.8	41.0	5.2	d1
Male	2	31	40.6	43.0	7.0	d1
Male	3	31	41.7	44.0	6.5	d1
Male	4	31	38.9	43.0	9.9	d1
Female	0	53	32.6	32.0	3.5	d2
Female	1	53	36.0	37.0	6.7	d2
Female	2	53	38.0	38.5	5.7	d2
Female	3	53	37.6	36.5	7.0	d2
Female	4	53	37.6	38.0	7.6	d2
Male	0	81	34.1	34.0	3.5	d2
Male	1	81	37.0	39.0	6.4	d2
Male	2	81	37.0	37.0	6.3	d2
Male	3	81	35.3	37.0	8.7	d2
Male	4	81	37.3	37.0	8.8	d2
Female	0	84	19.9	20.5	5.0	d3
Female	1	84	28.6	28.0	9.9	d3
Female	2	84	27.7	28.0	10.8	d3
Female	3	84	31.8	32.0	10.6	d3
Female	4	84	31.8	33.0	11.1	d3
Male	0	77	21.0	22.0	5.4	d3
Male	1	77	30.1	27.5	9.3	d3
Male	2	77	29.7	30.0	8.7	d3
Male	3	77	31.9	32.0	9.6	d3
Male	4	77	31.8	30.0	10.2	d3

OKS period: 0—baseline, 1—3 months postinjection, 2—6 months postinjection, 3—12 months postinjection, 4—24 months postinjection. Count: the number of patients in each group. Mean, median, and SD (standard deviation). Data: d1—baseline OKS of >39, d2—baseline , d3—baseline .